Evidence map›Paper›PMID 42757102›Full record

ArticleBlood vessels, thrombosis & hemostasis2026

Disease-specific safety and efficacy of DOACs vs LMWH for CAT in patients with brain metastases: a real-world analysis.

Ali Mushtaq, Omer Ashruf, Mohanad Baroudi, Ahmad Safdar, Alok A Khorana, Dana Angelini

Abstract read
In one paragraph

Article in Blood vessels, thrombosis & hemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ali MushtaqInternal Medicine, Cleveland Clinic, Cleveland, OH.
Omer AshrufInternal Medicine, Indiana University, Indianapolis, IN.
Mohanad BaroudiInternal Medicine, Cleveland Clinic, Cleveland, OH.
Ahmad SafdarInternal Medicine, Cleveland Clinic, Cleveland, OH.
Alok A KhoranaHematology & Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
Dana AngeliniHematology & Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.

Funding

Mechanisms of cancer immunotherapy-associated thrombosisR01HL164516 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI Claudia Marcela Diaz-Montero, ALOK A KHORANA · 2023 to 2026
$2.9M
(1/2) Statins to Prevent Cancer Associated Venous Thromboembolism (STAT-CAT): CCCUG3HL176627 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CONNORS, JEAN MARIE, KHORANA, ALOK A · 2025 to 2025
$2.3M
NHLBI NIH HHS R01 HL164516NHLBI NIH HHS UG3 HL176627
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42757102
PMCPMC13584105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.